LISATA THERAPEUTICS, INC. - LSTA

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$5.756M

QoQ value delta ($000)

+$4.408M (+327.0%)

Implied price effect (QoQ)

+129.82%

Total shares

1,328,611

QoQ shares delta

+613,542 (+85.8%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 35 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
VANGUARD CAPITAL MANAGEMENT LLC	1,361	271,815	0.0%
RENAISSANCE TECHNOLOGIES LLC	659	131,715	0.0%
VANGUARD GROUP INC	503	270,909	0.0%
DELTEC ASSET MANAGEMENT LLC	450	90,000	0.08%
Rangeley Capital, LLC	375	75,000	0.36%
GEODE CAPITAL MANAGEMENT, LLC	355	70,887	0.0%
CSS LLC/IL	310	61,898	0.01%
BlackRock, Inc.	274	54,857	0.0%
PenderFund Capital Management Ltd.	237	47,500	0.04%
Virtu Financial LLC	211	42,213	0.01%
VANGUARD FIDUCIARY TRUST CO	174	34,917	0.0%
GTS SECURITIES LLC	157	31,396	0.01%
STATE STREET CORP	126	25,348	0.0%
CITADEL ADVISORS LLC	113	22,666	0.0%
JBF Capital, Inc.	66	13,234	0.01%
Cerity Partners LLC	61	12,183	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	58	11,604	0.0%
BANK OF AMERICA CORP /DE/	51	10,353	0.0%
NORTHERN TRUST CORP	51	10,268	0.0%
HighTower Advisors, LLC	50	10,042	0.0%
ROYAL BANK OF CANADA	29	5,912	0.0%
SOL Capital Management CO	29	12,175	0.01%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC	25	5,000	0.0%
UBS Group AG	9	1,909	0.0%
Founders Capital Management	8	1,667	0.0%